MedPath

A clinical study on the improvement of inflammatory response around the wound in diabetic foot with encircling paste

Phase 1
Not yet recruiting
Conditions
diabetic foot
Registration Number
ITMCTR2200006147
Lead Sponsor
Dongzhimen Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1)Aged between 18 and 80 years old (inclusive), male and female;(2)Western medical diagnostic criteria consistent with diabetic foot;(3)Compliant with Diabetic Foot Infection (IDSA classification) grade 2-3,Ankle-brachial index = 0.7;(4)Glycated haemoglobin=8%;(5)Meets the criteria for the identification of diabetic foot ulcers in Chinese medicine as Yang evidence;(6)The patient gives informed consent and signs an informed consent form..

Exclusion Criteria

(1)Allergy or hypersensitivity to the test drug, its components or the control drug;(2) Serum albumin <25g/L, haemoglobin <90g/L, platelets <100 x 10^9/L;(3)Pregnant or planning to have a baby within 3 months, or pregnant or breastfeeding women;(4)Participants who have participated in a clinical study within 1 month prior to enrolment;(5)Severe cardiac, hepatic or renal insufficiency that seriously compromises the safety and treatment of the subject.In the judgment of the investigator, the patient is unable to complete the study or to comply with the requirements of the study;(6)Expected ulcer site debridement, percutaneous transluminal angioplasty (PTA) within 7 days prior to trial.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.